LA JOLLA, Calif., June 26, 2009 – Scientists at Burnham Institute for Medical Research (Burnham) have discovered that specific microRNAs (non-coding RNAs that interfere with gene expression) reduce ...
The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...
A new antiretroviral target has been identified that suppresses HIV-1 replication and selectively kills HIV-1-infected cells. HIV-1 is the most common type of HIV. When HIV-1 leaves infected cells, ...
Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...
The success of HIV entry inhibitors -- new drugs which prevent HIV entry into host cells -- are analyzed in a New Drug Class review in this week's edition of the Lancet. The study, by Dr Jose Este, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback